U
Uwe Wollina
Researcher at Dresden University of Technology
Publications - 1081
Citations - 14682
Uwe Wollina is an academic researcher from Dresden University of Technology. The author has contributed to research in topics: Medicine & Psoriasis. The author has an hindex of 48, co-authored 1033 publications receiving 12459 citations. Previous affiliations of Uwe Wollina include University of Jena & Medical University Plovdiv.
Papers
More filters
Journal ArticleDOI
Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
TL;DR: The timing of cutaneous adverse effects (psoriasis and psoriasiform rash) varied considerably among patients, ranging from after a single application to a delayed response of up to 63 months after initiation of treatment.
Journal ArticleDOI
Pyoderma gangrenosum – a review
TL;DR: Pyoderma gangrenosum is a rare noninfectious neutrophilic dermatosis that starts with sterile pustules that rapidly progress and turn into painful ulcers of variable depth and size with undermined violaceous borders.
Journal ArticleDOI
The spectrum of WRN mutations in Werner syndrome patients
Shurong Huang,Lin Lee,Nancy B. Hanson,Catherine Lenaerts,Holger Hoehn,Martin Poot,Craig D. Rubin,Da Fu Chen,Chih-Chao Yang,Heike Juch,Thomas Dorn,Roland Spiegel,Elif A. Oral,Mohammed Abid,Carla Battisti,Emanuela Lucci-Cordisco,Giovanni Neri,Erin H. Steed,Alexa Kidd,William L. Isley,David Showalter,Janet L. Vittone,A. Konstantinow,Johannes Ring,Peter Meyer,Sharon L. Wenger,Sharon L. Wenger,Axel von Herbay,Axel von Herbay,Uwe Wollina,Markus Schuelke,Carin R. Huizenga,Dru F. Leistritz,George M. Martin,I. Saira Mian,Junko Oshima +35 more
TL;DR: The present communication summarizes, from among 99 WS subjects, the spectrum of 50 distinct mutations discovered by the authors' group and by others since the WRN gene was first cloned in 1996; 25 of these have not previously been published.
Journal ArticleDOI
Cutaneous signs in COVID-19 patients: A review.
Uwe Wollina,Ayse Serap Karadag,Christopher Rowland-Payne,Anca Chiriac,Anca Chiriac,Torello Lotti +5 more
TL;DR: This review will describe cutaneous symptoms of patients of all ages in association with COVID‐19 and focus on disorders that are caused by direct action of SARS‐CoV‐2 on tissues, complement, and coagulation system and on nonspecific eruption of the systemic viral infection.
Journal Article
Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia.
TL;DR: The detection of cytokines in FM skin indicates the presence of inflammatory foci (neurogenic inflammation) in the skin of certain patients (about 30% of FM patients), suggesting an inflammatory component in the induction of pain.